0001104659-23-081714.txt : 20230717 0001104659-23-081714.hdr.sgml : 20230717 20230717182201 ACCESSION NUMBER: 0001104659-23-081714 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230714 FILED AS OF DATE: 20230717 DATE AS OF CHANGE: 20230717 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRAF FINCKENSTEIN FRIEDRICH CENTRAL INDEX KEY: 0001782981 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36860 FILM NUMBER: 231092584 MAIL ADDRESS: STREET 1: 999 SKYWAY ROAD STREET 2: SUITE 150 CITY: SAN CARLOS STATE: CA ZIP: 94070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IOVANCE BIOTHERAPEUTICS, INC. CENTRAL INDEX KEY: 0001425205 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 753254381 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 825 INDUSTRIAL ROAD STREET 2: 4TH FLOOR CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 6502607120 MAIL ADDRESS: STREET 1: 825 INDUSTRIAL ROAD STREET 2: 4TH FLOOR CITY: SAN CARLOS STATE: CA ZIP: 94070 FORMER COMPANY: FORMER CONFORMED NAME: Lion Biotechnologies, Inc. DATE OF NAME CHANGE: 20131015 FORMER COMPANY: FORMER CONFORMED NAME: Genesis Biopharma, Inc DATE OF NAME CHANGE: 20100319 FORMER COMPANY: FORMER CONFORMED NAME: FREIGHT MANAGEMENT CORP DATE OF NAME CHANGE: 20080128 4 1 tm2321428-2_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-07-14 0 0001425205 IOVANCE BIOTHERAPEUTICS, INC. IOVA 0001782981 GRAF FINCKENSTEIN FRIEDRICH C/O IOVANCE BIOTHERAPEUTICS, INC. 825 INDUSTRIAL ROAD, 4TH FLOOR SAN CARLOS CA 94070 0 1 0 0 Chief Medical Officer 0 Common Stock 2023-07-14 4 M 0 2813 0 A 32348 D Common Stock 2023-07-14 4 F 0 1395 7.76 D 30953 D Restricted Stock Units 2023-07-14 4 M 0 2813 0.00 D Common stock 2813 16877 D Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities. Represents the common stock remaining after deducting the common stock withheld for taxes. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The remaining RSUs will vest in six equal quarterly installments. /s/ Friedrich Graf Finckenstein 2023-07-17